Equities research analysts at Zacks Research reduced their Q2 2026 earnings per share (EPS) estimates for Pfizer in a report issued on Thursday, March 20th. Zacks Research analyst K. Shah now ...

Investing.com -- U.S. stocks were sinking as investors await the outcome of the Federal Reserve’s two-day meeting, which starts... (Reuters) - A look at the day ahead in U.S. and global markets ...

Asian shares are mixed after gains in technology stocks snapped Wall Street’s four-week losing streak. Investors are awaiting ...

Zacks Investment Research Image Source: Zacks Investment Research Presently, Pfizer looks like a discounted stock as well. This is because, according to the price/earnings ratio, Pfizer stock ...

Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...

Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

Pfizer shares are trading lower Wednesday after a Wall Street Journal report revealed that U.S. prosecutors are investigating ...

Quote: The latest dividend declarations, combined with stock price movements, have pushed PFE’s yield to be almost twice as JNJ’s. But I want to caution you to look beyond yield (and P/E too ...